• 27 June, 2025

Suven to do phase IV trials for US firm

March 09, 2005 | Wednesday | News

Suven Life Sciences has signed a contract with United Therapeutics Corp., USA, for conduct of Phase IV clinical trials on United's product in India. The initial contract is valued at $2.5 million and the 15-months study would be conducted in over 30 institutions in India.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s Integrated DigiTech targeting Affordable Healthcare Access?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy